Hyperdynamic syndrome is a well-known clinical condition found in patients with cirrhosis
and portal hypertension, characterized by increased heart rate and cardiac output, and …

We review the role of liver ultrasonography (US) and related techniques as non-invasive
tools in predicting metabolic derangements, liver histology, portal hypertension and …

Non-alcoholic fatty liver disease (NAFLD) encompasses pure steatosis through nonalcoholic
steatohepatitis (NASH) and is the most common cause of chronic liver disease in Western …

Background Nonalcoholic fatty liver disease (NAFLD) is associated increased
cardiovascular events and mortality. Coronary artery calcium scanning (CAC) is the robust …

Introduction Nonalcoholic fatty liver disease (NAFLD) encompasses simple steatosis and
steatohepatitis (NASH) with or without fibrosis/cirrhosis and hepatocellular carcinoma …

Objectives To determine whether severity of non-alcoholic fatty liver disease (NAFLD) and
liver fibrosis quantitatively assessed in individuals with diabetes mellitus (DM)-2 correlate …

Objective: Cardiovascular disease is a leading cause of death in postmenopausal women,
and nonalcoholic fatty liver disease (NAFLD) has been known to be associated with …

Nonalcoholic fatty liver disease (NAFLD) has become an emerging health issue with a high
prevalence in general population. The cross-sectional study was performed to investigate …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in
Western countries and can progress from simple steatosis to nonalcoholic steatohepatitis …

Nonalcoholic fatty liver disease (NAFLD) refers to the accumulation of fat (mainly
triglycerides) within hepatocytes. Approximately 20%-30% of adults in the general …